More
    Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    CytexOrtho gets FDA approval for first-in-human trial of absorbable hip implants

    CytexOrtho today said it has approval from the FDA to start a Phase 1 clinical trial evaluating the safety and efficacy of its absorbable...

    Positive data for Cardiawave’s ultrasound tech that treats calcified aortic stenosis

    Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in a pivotal study. The investigational...

    Sonablate enrols first patient in incompetent vein ablation clinical trial

    Sonablate announced the first patient enrolment in its HIFIVE U.S. clinical trial, which is testing high-intensity focused ultrasound (HIFU) for the noninvasive treatment of...

    BlueWind Medical reports positive data for tibial neuromod

    BlueWind Medical shared two-year data from the OASIS pivotal study of its implantable tibial neuromodulation (iTNM) system. Park City, Utah-based BlueWind said investigators presented...

    Corvia Medical has positive data for atrial shunt

    Corvia Medical announced three-year positive results from its clinical trial of its Corvia Atrial Shunt. The REDUCE LAP-HF randomized trial evaluated the safety and efficacy...

    Shifamed’s Tioga Cardiovascular has first human cases with mitral valve replacement

    Tioga Cardiovascular, a Shifamed portfolio company, announced the first-in-human implants for its Luna TMVR system. Luna, a 28 Fr. transcatheter mitral valve replacement (TMVR) system,...

    Luna Diabetes launches trial for ‘world’s smallest insulin patch pump’

    Luna Diabetes launched a pivotal trial for Luna, its miniature automated insulin delivery system. The company describes the system — designed to transform nighttime...

    Nexalin trials Halo neurostimulation device in traumatic brain injury

    Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset,...

    SeaStar hits halfway mark in AKI trial for selective cytopheretic device

    SeaStar Medical has announced a significant milestone in its pivotal NEUTRALIZE-AKI trial with 51 subjects enrolled, surpassing the halfway point toward its target of...
    1...111213...57Page 12 of 57

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices